Vahanian & Associates Financial Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$275K Sell
956
-8
-0.8% -$2.18K 1.09% 34
2023
Q3
$259K Sell
964
-30
-3% -$7.49K 0.83% 44
2023
Q2
$221K Sell
994
-1,190
-54% -$276K 0.7% 47
2023
Q1
$528K Sell
2,184
-122
-5% -$29.9K 1.46% 18
2022
Q4
$606K Buy
2,306
+103
+5% +$27.6K 1.98% 17
2022
Q3
$497K Buy
+2,203
New +$534K 1.71% 19

Other funds holding AMGN

Vahanian & Associates Financial Planning's AMGN Position: Q4 2023 in Review

Vahanian & Associates Financial Planning reduced its Amgen (AMGN) stake by 0.83% in Q4 2023, selling an estimated $2.18K and leaving 956 shares worth $275K. The position accounts for 1.09% of the portfolio, ranked #34.

Vahanian & Associates Financial Planning first reported a position in AMGN in Q3 2022 and has held it in 6 quarters since. The position peaked at $606K in Q4 2022. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Vahanian & Associates Financial Planning held 956 shares of Amgen worth $275K as of Q4 2023.
  • Vahanian & Associates Financial Planning sold 8 Amgen shares in Q4 2023, an estimated $2.18K.
  • Amgen made up 1.09% of Vahanian & Associates Financial Planning's portfolio in Q4 2023, its #34 holding.
  • Vahanian & Associates Financial Planning first reported a position in Amgen in Q3 2022 and has held it in 6 quarters since.
  • Vahanian & Associates Financial Planning's Amgen position peaked at $606K in Q4 2022.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Vahanian & Associates Financial Planning's 13F filing for Q4 2023, filed 25 Jan 2024.